Dr. Reddy's Laboratories SA, subsidiary of Dr. Reddy's Laboratories Ltd. (RDY), and Coya Therapeutics, Inc. (COYA) have entered into a development and license agreement for the development and commercialization of COYA 302, an investigational combination therapy for the treatment of Amyotrophic Lateral Sclerosis.